Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 |
| NDC | 68180-982-01 |
| Full product label | Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | U.S.A. Nationwide |
| Quantity | 25,944 bottles |
| Recall initiated | 2020-04-01 |
| Report date | 2020-04-08 |
| Recall completed | 2021-06-30 |
| Recall number | D-1079-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗